82 results

Life sciences investment company Malin Corp has announced the completion of the previously announced sale of its investee company Kymab to Sanofi for (...)

Analysts are talking of a price target for Malin of as much as €8.80 – some way off its €10 IPO price but well above Monday’s close at €6. Photograph: Kena Betancurs

Dublin-listed life sciences investment company Malin’s market value has risen by 11 per cent – or €28 million – over the past two sessions to almost €(...)

Immunocore says  proceeds from the IPO will be used to advance its lead product candidate through the completion of its phase-three clinical trial as well as preparing for its commercial launch

Immunocore, a UK biotech company in which Dublin-listed Irish life sciences investment company Malin has a 6 per cent stake, has filed to raise $258 m(...)

Immunocore has hired investment banks Goldman Sachs, JP Morgan and Jefferies to manage the planned IPO ahead of a listing in the Nasdaq in New York

Immunocore, a UK biotech company in which Dublin-listed Irish life sciences investment company Malin has a 7.4 per cent stake, has filed to raise $100(...)

On Monday, Malin announced that one of the key companies in which it is invested, Kymab, is to be sold to French drugs giant Sanofi in a deal worth up to $1.45 billion (€1.2bn). Image: iStock

Almost six years after Malin Corp raised €330 million through an initial public offering (IPO) on the back of the reputation of its founders, a group (...)

French multinational pharmaceutical company Sanofi’s headquarters in Paris. Photograph: Philippe Wojazer/Reuters

Irish life sciences investment group Malin is set to net up to about $145 million (€120 million) from the sale of British immunotherapy firm Kymab to (...)

Life sciences investment firm Malin Corporation has pledged to return capital to shareholders as it seeks to benefit from opportunities created by the(...)

Minister for Finance Paschal Donohoe and Minister for Public Expenditure Michael McGrath in Government Buildings in Dublin on Tuesday. Photograph:  Julien Behal Photography/PA Wire

Our team of business and political reporters have been working flat out to bring you everything you need to know about Budget 2021. Online this mornin(...)

Poseida is a human therapeutics company using genome engineering technologies to develop treatments.

Poseida Therapeutics, a company in which Dublin-listed life-sciences investment group Malin has a significant stake, has announced the pricing of its (...)

Malin’s stock trades at about €5, some 35 per cent below what it estimates to be its “intrinsic equity value” as of the end of 2019. Photograph: iStock

Shares in life sciences investment company Malin, which have rallied by over 250 per cent from their March lows, continue to trade well below their re(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »